MAPT and Alzheimer disease: Analyses of cerebrospinal fluid have demonstrated that individuals with diffuse malignant subtypes are more likely to present a cerebrospinal fluid profile similar to Alzheimer’s disease (AD), characterized by reduced β-amyloid levels and elevated tau concentrations [35].